Geneva, Oct. 9 -- International Clinical Trials Registry received information related to the study (NCT07855497) titled 'Efficacy and Safety of Second-Line Helicobacter Pylori Eradication' on Sept. 28.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: Seoul National University Bundang Hospital
Condition:
HELICOBACTER PYLORI INFECTIONS
Intervention:
Drug: P-CAB-BM quadruple regimen
Recruitment Status: Not recruiting
Phase: N/A
Date of First Enrollment: February 1, 2021
Target Sample Size: 141
Countries of Recruitment:
South Korea
To know more, visit https://clinicaltrials.gov/study/NCT07855497
...